Association of miR-608 rs4919510 polymorphism and cancer risk: A meta-analysis based on 13,664 subjects

Oncotarget

Volumn 8, Issue 23, 2017, Pages 37023-37031

  Liu, Huiquan ^a   Zhou, Yaqun ^a   Liu, Qingquan ^a   Xiao, Guangqin ^a   Wang, Bangyan ^a   Li, Weijuan ^a   Ye, Dawei ^a   Yu, Shiying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cancer risk; Meta analysis; MiR 608; Polymorphism; Rs4919510

Indexed keywords

MICRORNA; MICRORNA 608; UNCLASSIFIED DRUG; MIRN608 MICRORNA, HUMAN;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COLORECTAL CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ETHNIC DIFFERENCE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; SYSTEMATIC REVIEW; THYROID CANCER; CARCINOGENESIS; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; META ANALYSIS; NEOPLASM; ODDS RATIO; RISK FACTOR;

CARCINOGENESIS; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICRORNAS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 85020237303     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9509     Document Type: Article

References (34)

1. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012; 13:249-58
2. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007; 302:1-12
3. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215-33
4. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6:857-66
5. Anglicheau D, Muthukumar T, Suthanthiran M. MicroRNAs: small RNAs with big effects. Transplantation. 2010; 90:105-12
6. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010; 9:775-89
7. Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, Liu ZH, Peng JY, Zhou YK, Qin HL. A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep. 2012; 39:269-75
8. Mishra PJ, Bertino JR. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics. 2009; 10:399-416
9. Gao Y, Liu Y, Liu GL, Ran LK, Zeng F, Wu JY, Song FZ. Association between the pre-mir-218 polymorphism and cancer risk in the Chinese population: a meta-analysis. Asian Pac J Cancer Prev. 2014; 15:2517-22
10. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010; 10:389-402
11. Schetter AJ, Harris CC. Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol. 2011; 38:734-42
12. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 2010; 31:1805-12
13. Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu X. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res. 2012; 18:3982-91
14. Pardini B, Rosa F, Naccarati A, Vymetalkova V, Ye Y, Wu X, di Gaetano C, Buchler T, Novotny J, Matullo G, Vodicka P. Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients. Carcinogenesis. 2015; 36:82-6
15. Yang PW, Huang YC, Hsieh CY, Hua KT, Huang YT, Chiang TH, Chen JS, Huang PM, Hsu HH, Kuo SW, Kuo ML, Lee JM. Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma. Ann Surg Oncol. 2014; 21:601-9
16. Zheng J, Deng J, Xiao M, Yang L, Zhang L, You Y, Hu M, Li N, Wu H, Li W, Lu J, Zhou Y. A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma. Cancer Res. 2013; 73:5151-62
17. Qiu F, Yang L, Zhang L, Yang X, Yang R, Fang W, Wu D, Chen J, Xie C, Huang D, Zhou Y, Lu J. Polymorphism in mature microRNA-608 sequence is associated with an increased risk of nasopharyngeal carcinoma. Gene. 2015; 565:180-6
18. Ryan BM, McClary AC, Valeri N, Robinson D, Paone A, Bowman ED, Robles AI, Croce C, Harris CC. rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS One. 2012; 7:e36306
19. Zhang P, Wang J, Lu T, Wang X, Zheng Y, Guo S, Yang Y, Wang M, Kolluri VK, Qiu L, Shen F, Fan L, Li J, Wang Y, Wei Q, Jin L, et al. miR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population. Tumour Biol. 2015; 36:8789-95
20. Yin Z, Cui Z, Guan P, Li X, Wu W, Ren Y, He Q, Zhou B. Interaction between Polymorphisms in Pre-MiRNA Genes and Cooking Oil Fume Exposure on the Risk of Lung Cancer in Chinese Non-Smoking Female Population. PLoS One. 2015; 10:e0128572
21. Wei WJ, Wang YL, Li DS, Wang Y, Wang XF, Zhu YX, Pan XD, Wang ZY, Wu Y, Jin L, Wang JC, Ji QH. Association study of single nucleotide polymorphisms in mature microRNAs and the risk of thyroid tumor in a Chinese population. Endocrine. 2015; 49:436-44
22. Wang R, Zhang J, Ma Y, Chen L, Guo S, Zhang X, Ma Y, Wu L, Pei X, Liu S, Wang J, Hu H, Liu J. Association study of miR149 rs2292832 and miR608 rs4919510 and the risk of hepatocellular carcinoma in a largescale population. Mol Med Rep. 2014; 10:2736-44
23. Kupcinskas J, Wex T, Link A, Leja M, Bruzaite I, Steponaitiene R, Juzenas S, Gyvyte U, Ivanauskas A, Ancans G, Petrenkiene V, Skieceviciene J, Kupcinskas L, Malfertheiner P. Gene polymorphisms of micrornas in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer. PLoS One. 2014; 9:e87467
24. Kupcinskas J, Bruzaite I, Juzenas S, Gyvyte U, Jonaitis L, Kiudelis G, Skieceviciene J, Leja M, Pauzas H, Tamelis A, Pavalkis D, Kupcinskas L. Lack of association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 gene polymorphisms and colorectal cancer. Sci Rep. 2014; 4:5993
25. Huang AJ, Yu Kd Fau-Li J, Li J Fau-Fan L, Fan L Fau-Shao Z-M, Shao ZM. Polymorphism rs4919510: C>G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes. PLoSOne. 2012; 7:e35252
26. Dong G, Zhang R, Xu J, Guo Y. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility. Int J Clin Exp Pathol. 2015; 8: 13450-7
27. Frixa T, Donzelli S, Blandino G. Oncogenic MicroRNAs: Key Players in Malignant Transformation. Cancers (Basel). 2015; 7:2466-85
28. Kang Z, Li Y Fau-He X, He X Fau-Jiu T, Jiu T Fau-Wei J, Wei J Fau-Tian F, Tian F Fau-Gu C, Gu C. Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and cancer risk: evidence based on 45, 816 subjects. Tumor Biol. 2014; 35:6271-82
29. Zhang Y, Schiff D, Park D, Abounader R. MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. PLoS One. 2014; 9:e91546
30. Yang H, Li Q, Niu J, Li B, Jiang D, Wan Z, Yang Q, Jiang F, Wei P, Bai S. microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10. Oncotarget.2016; 7: 2709-20. doi: 10.18632/oncotarget.6458
31. Bangshun He, Yuqin Pan, William C. Cho, Yeqiong Xu, Ling Gu, Zhenglin Nie, Liping Chen, Guoqi Song1, Tianyi Gao1, Rui Li1, Shukui Wang. The Association between Four Genetic Variants inMicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and Cancer Risk: Evidence from PublishedStudies. PLoSOne.2012; 7:e49032
32. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22:719-48
33. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177-88
34. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629-34